Thermo Fisher Scientific Inc., the world leader in serving science, will exhibit a new spectrophotometer that offers unique benefits for human leukocyte antigen (HLA) typing laboratories dealing with donor tissue matching. The Thermo Scientific NanoDropâ„¢ 1000 represents the growing trend of successful genome research tools finding their way to the clinical research setting.

Two international teams of scientists working on independent studies have discovered that rare deletions and duplications in genetic material appear to occur in greater numbers in people who have schizophrenia. The studies are published in the July 30th online issue of the journal Nature.

Details on Elan and Wyeth’s new Alzheimer’s drug show it raised risks of a potentially serious side effect, but may help those who do not have a genetic risk for the disease.

Autopsies usually point to a cause of death but now a study of brain tissue collected during these procedures, may explain an underlying cause of major depression and suicide. The international research group, led by Dr. Michael O. Poulter of Robarts Research Institute at The University of Western Ontario and Dr.

In a major paper published in the online edition of the journal Nature, scientists from deCODE genetics (Nasdaq: DCGN) and the University of Iceland, along with academic colleagues from the deCODE-led European SGENE consortium, China and the United States, report the discovery of three rare deletions in the human genome that confer risk of schizophrenia.

Researchers at the Max Delbruck Center for Molecular Medicine (MDC) Berlin-Buch, Germany, have generated new findings on how microRNAs (miRNA) regulate protein expression. Two teams lead by Matthias Selbach (Proteomics) and Nikolaus Rajewsky (Systems Biology) have shown that a single miRNA can directly regulate synthesis of hundreds of different proteins. In this way, miRNAs can program the way human cells act, they report in the latest issue of the journal Nature (doi:10.

Medical College of Wisconsin researchers in Milwaukee have reported that children of Alzheimer's patients who are carriers of a genetic risk factor for Alzheimer's disease have neurological changes that are detectable long before clinical symptoms may appear.